Rodolfo Mazzoncini
University of Verona
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rodolfo Mazzoncini.
Acta Psychiatrica Scandinavica | 2010
Rodolfo Mazzoncini; Kim Donoghue; Jozella Hart; Craig Morgan; Gillian A. Doody; Paola Dazzan; Peter B. Jones; Kevin Morgan; Robin M. Murray; Paul Fearon
Mazzoncini R, Donoghue K, Hart J, Morgan C, Doody GA, Dazzan P, Jones PB, Morgan K, Murray RM, Fearon P. Illicit substance use and its correlates in first episode psychosis.
Psychiatry Research-neuroimaging | 2014
Kim Donoghue; Gillian A. Doody; Robin M. Murray; Peter B. Jones; Craig Morgan; Paola Dazzan; Jozella Hart; Rodolfo Mazzoncini; James H. MacCabe
An earlier age of onset of schizophrenia has been identified as a poor prognostic indicator. The current study examines the interaction effect of gender and cannabis use on age of onset of schizophrenia and schizoaffective disorder. This research forms part of a two-centre epidemiological study of first-episode psychosis and included individuals with a diagnosis of schizophrenia or schizoaffective disorder and an age of onset between age 16 and 45. Kaplan-Meier curves and Cox proportional hazards regression were used to compare the effects of cannabis use and gender on age of first symptom of schizophrenia. Akaikes information criteria were used to find the model with the best fit to the data. Cannabis users had an earlier age of first symptom than non-users. There was an interaction with gender; the gender difference in age of onset was diminished in cannabis smokers compared with non-cannabis smokers. The model including cannabis use interacting with gender was the most parsimonious model, followed by cannabis use alone. The addition of other illegal drug use did not improve the model. Cannabis use is associated with an earlier age of onset of schizophrenia, and the gender difference in age of onset is reduced among cannabis smokers.
Journal of Psychiatric Research | 2013
Sarah Tosato; Antonio Lasalvia; Chiara Bonetto; Rodolfo Mazzoncini; Doriana Cristofalo; Katia De Santi; Mariaelena Bertani; Sarah Bissoli; Lorenza Lazzarotto; Giovanna Marrella; Dario Lamonaca; Rosanna Riolo; Francesco Gardellin; Anna Urbani; Michele Tansella; Mirella Ruggeri
Cannabis use is frequent among first-episode psychosis (FEP) patients and has been associated with several clinical features. This study aimed in an FEP sample to determine whether cannabis use is associated with (1) a higher level of positive symptoms, a lower level of depression and a better premorbid adjustment, (2) an earlier age of onset, and a better premorbid IQ. The study was conducted within the framework of the Psychosis Incident Cohort Outcome Study (PICOS), a multisite collaborative research on FEP patients who attended the psychiatric services in Veneto Region, Italy. Standardized instruments were used to collect sociodemographic, clinical, and drug use data. A total of 555 FEP patients met the inclusion criteria, 517 of whom received an ICD-10 diagnosis of psychosis; 397 (55% males; mean age: 32 yrs ± 9.5) were assessed. Out of these, 311 patients agreed to be interviewed on drug and alcohol misuse; 20.3% was positive for drug misuse: cannabis (19.0%), cocaine (3.9%), and hallucinogens (3.9%). Cannabis use was not associated with a higher level of positive symptoms, but correlated with less severe depressive symptoms. No relationship was observed between premorbid adjustment or IQ and cannabis use. FEP patients who used cannabis had an earlier age of onset than abstinent patients, even after adjusting for gender and diagnosis. Our results suggest a possible causal role of cannabis in triggering psychosis in certain vulnerable subjects. Particular attention must be paid to this behaviour, because reducing cannabis use can delay or prevent some cases of psychosis.
Psychological Medicine | 2012
Mariaelena Bertani; Antonio Lasalvia; Chiara Bonetto; Sarah Tosato; Doriana Cristofalo; Sarah Bissoli; K. De Santi; Rodolfo Mazzoncini; Lorenza Lazzarotto; Maensiri Santi; A. Sale; D. Scalabrin; M. Abate; Michele Tansella; Mirella Ruggeri
BACKGROUND. This paper examined the hypothesis that males with first-episode psychosis (FEP) experience lower pre-morbid adjustment, greater social disability and more self-perceived needs at illness onset than females(by controlling for duration of untreated psychosis, diagnosis, age and symptoms at onset). Results disconfirming this hypothesis were thought to suggest the potentially mediating role of social context in determining the impact of symptoms and disability on the everyday lives of male patients in the early phase of psychosis. METHOD. A large epidemiologically representative cohort of FEP patients (n=517) was assessed within the Psychosis Incident Cohort Outcome Study (PICOS) framework – a multi-site research project examining incident cases of psychosis in Italys Veneto region. RESULTS. Despite poorer pre-morbid functioning and higher social disability at illness onset, males reported fewer unmet needs in the functioning domain than females did. An analysis of help provided by informal care givers showed that males received more help from their families than females did. This finding led us to disconfirm the second part of the hypothesis and suggest that the impact of poorer social performance and unmet needs on everyday life observed in male patients might be hampered by higher tolerance and more support within the family context.CONCLUSIONS. These findings shed new light on rarely investigated sociocultural and contextual factors that may account for the observed discrepancy between social disability and needs for care in FEP patients. They also point to a need for further research on gender differences, with the ultimate aim of delivering gender-sensitive effective mental health care.
Acta Psychiatrica Scandinavica | 2012
Kim Donoghue; Rodolfo Mazzoncini; Jozella Hart; Jolanta Zanelli; Craig Morgan; Paola Dazzan; Kevin Morgan; Robin M. Murray; Peter B. Jones; Gillian A. Doody
Donoghue K, Mazzoncini R, Hart J, Zanelli J, Morgan C, Dazzan P, Morgan KD, Murray RM, Jones PB, Doody GA. The differential effect of illicit drug use on cognitive function in first‐episode psychosis and healthy controls.
World Journal of Biological Psychiatry | 2009
Rodolfo Mazzoncini; Michele Zoli; Sarah Tosato; Antonio Lasalvia; Mirella Ruggeri
Schizophrenia is one of the most severe psychiatric disorders. Despite the knowledge accumulated over years, aetiology and pathophysiology remain uncertain. Research on families and twins suggests that genetic factors are largely responsible for the disease and implies specific genes as risk factors. Genetic epidemiology indicates a complex transmission mode, compatible with a multi-locus model, with single genes accounting for specific traits rather than for the entire phenotype. To better understand every single gene contribution to schizophrenia, the use of intermediate endophenotypes has been proposed. A straight communication between preclinical and clinical researchers could facilitate research on the association between genes and endophenotypes. Many behavioural tasks are available for humans and animals to measure endophenotypes. Here, firstly, we reviewed the most promising mouse behavioural tests modelling human behavioural tasks altered in schizophrenia. Secondly, we systematically reviewed animal models availability for a selection of candidate genes, derived from linkage and association studies. Thirdly, we systematically reviewed the studies which tested mutant mice in the above behavioural tasks. Results indicate a large mutant mice availability for schizophrenia candidate genes but they have been insufficiently tested in behavioural tasks. On the other hand, multivariate and translational approach should be implemented in several behavioural domains.
International Journal of Psychiatry in Clinical Practice | 2015
Elisa Ira; Chiara Bonetto; Martina Zanoni; Alessandro Bottacini; Rodolfo Mazzoncini; Lisa Martini; Angela Garozzo; Antonio Lasalvia; Michele Tansella; Mirella Ruggeri; Sarah Tosato
Objective. Prepulse inhibition (PPI) of the startle reflex deficit and neurological soft signs (NSS) are two markers of vulnerability to psychosis. This study investigated the possibility of a PPI–NSS relation due to a putative common biological substrate, hypothesizing that patients with higher NSS scores also show higher PPI deficits. Moreover, we examined the possibility of an association of PPI deficits and NSS with negative symptoms. Methods. Fifteen subjects with psychosis and fifteen healthy controls underwent PPI and NSS evaluations. Results. Patients did not exhibit higher PPI deficits but only higher NSS rates (p < 0.01), as compared with healthy controls. Higher NSS rates were not associated with PPI deficits, and NSS sensory integration signs correlated positively with negative symptoms (p < 0.01). Conclusion. Our study supported the hypothesis that NSS are trait markers whereas PPI deficits state markers and that their putative common biological substrate is not sufficient to determinate an association between them. The study hypothesis, however, needs further investigation.
Epidemiology and Psychiatric Sciences | 2012
Antonio Lasalvia; Sarah Tosato; Paolo Brambilla; Mariaelena Bertani; Chiara Bonetto; Doriana Cristofalo; Sarah Bissoli; K. De Santi; Lorenza Lazzarotto; Gioia Zanatta; Giovanna Marrella; Rodolfo Mazzoncini; M. Zanoni; N. Garzotto; C. Dolce; Stylianos Nicolau; Luana Ramon; Cinzia Perlini; Gianluca Rambaldelli; Marcella Bellani; Michele Tansella; Mirella Ruggeri
Schizophrenia Research | 2012
Elisa Ira; Sarah Tosato; Chiara Bonetto; Martina Zanoni; Rodolfo Mazzoncini; Lisa Martini; Angela Garozzo; Antonio Lasalvia; Michele Tansella; Mirella Ruggeri
Schizophrenia Research | 2010
Kim Donoghue; Rodolfo Mazzoncini; Jozella Hart; Jolanta Zanelli; Kevin Morgan; Paola Dazzan; Craig Morgan; Peter B. Jones; Robin M. Murray; Gillian A. Doody